Noninvasive Imaging Methods for Quantification of Pulmonary Edema and Congestion: A Systematic Review.
extravascular lung water
grading
lung water
pulmonary edema
review
Journal
JACC. Cardiovascular imaging
ISSN: 1876-7591
Titre abrégé: JACC Cardiovasc Imaging
Pays: United States
ID NLM: 101467978
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
received:
20
10
2022
revised:
28
06
2023
accepted:
29
06
2023
medline:
10
11
2023
pubmed:
27
8
2023
entrez:
26
8
2023
Statut:
ppublish
Résumé
Quantification of pulmonary edema and congestion is important to guide diagnosis and risk stratification, and to objectively evaluate new therapies in heart failure. Herein, we review the validation, diagnostic performance, and clinical utility of noninvasive imaging modalities in this setting, including chest x-ray, lung ultrasound (LUS), computed tomography (CT), nuclear medicine imaging methods (positron emission tomography [PET], single photon emission CT), and magnetic resonance imaging (MRI). LUS is a clinically useful bedside modality, and fully quantitative methods (CT, MRI, PET) are likely to be important contributors to a more accurate and precise evaluation of new heart failure therapies and for clinical use in conjunction with cardiac imaging. There are only a limited number of studies evaluating pulmonary congestion during stress. Taken together, noninvasive imaging of pulmonary congestion provides utility for both clinical and research assessment, and continued refinement of methodologic accuracy, validation, and workflow has the potential to increase broader clinical adoption.
Identifiants
pubmed: 37632500
pii: S1936-878X(23)00339-X
doi: 10.1016/j.jcmg.2023.06.023
pii:
doi:
Types de publication
Systematic Review
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1469-1484Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Funding Support and Author Disclosures Dr Lindow is supported by the Swedish Heart Lung Foundation (20200553), Swedish Cardiac Society, Royal Swedish Academy of Sciences (LM2019-0013), Women and Health Foundation, Region Kronoberg (8301), Swedish Heart and Lung Association, Swedish Association of Clinical Physiology, and Scandinavian Society of Clinical Physiology and Nuclear Medicine. This review was supported in part by grants to Dr Ugander from the University of Sydney, New South Wales Health, and Heart Research Australia. All of the authors are affiliated with the University of Sydney or Karolinska Institute, and both institutions have research and developments agreements with Siemens for cardiac magnetic resonance. Siemens had no role in the conceptualization, design, data collection, analysis, decision to publish, or preparation of the manuscript.